gms | German Medical Science

27. Wissenschaftlicher Kongress der Deutschen Hochdruckliga

Deutsche Liga zur Bekämpfung des hohen Blutdrucks – Deutsche Hypertonie Gesellschaft e. V.

26. bis 29.11.2003, Bonn

Article

Send article

Short-term changes of antihypertensive therapy according to the guidelines of the German Hypertension League

Kurzfristige Änderungen der antihypertensiven Therapie nach Leitlinienempfehlung der Deutschen Hochdruckliga

Meeting Abstract (Hypertonie 2003)

Search Medline for

  • presenting/speaker S. Eckert - Herz- und Diabeteszentrum NRW, Cardiac Research Unit (Bad Oeynhausen, D)
  • A. Albers - Herz- und Diabeteszentrum NRW, Cardiac Research Unit (Bad Oeynhausen, D)
  • A. Häring - Herz- und Diabeteszentrum NRW, Cardiac Research Unit (Bad Oeynhausen, D)
  • D. Horstkotte - Herz- und Diabeteszentrum NRW, Cardiac Research Unit (Bad Oeynhausen, D)

Hypertonie 2003. 27. Wissenschaftlicher Kongress der Deutschen Hochdruckliga. Bonn, 26.-29.11.2003. Düsseldorf, Köln: German Medical Science; 2004. Doc03hochP16

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/hoch2003/03hoch116.shtml

Published: November 11, 2004

© 2004 Eckert et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.

Outline

Text

Since November 2002, angiotensin-1 receptor antagonists (AT-1)are recommended as first-class drugs in antihypertensive therapy. We investigated the prescription behaviour of general practitioners during the first 6 months after the guidelines of the German Hypertension League have been changed.

Methods

255 hypertensive patients on drug therapy were prospectively investigated and compared to the data of a prospective study (n=100 hypertensive patients) performed between March and June 2002. Patients with blood pressure values < 140/90 mmHg were classified as adequately treated. All patients underwent cardiac catheterization. 48% of patients with coronary heart disease had interventional therapy. 62% of all patients received statin therapy. LDL cholesterol values were 116±36 U/l.

Results

In 2003, more hypertensive patients were treated with AT-1 and less with ACE inhibitors (ACE-I) and b-receptor blockers (b-B). There are no significant changes in diuretics (D) and calcium channel blockers (CCB) (Chi²-test).

[Tab. 1]

Conclusions

In 2003, more hypertensive patients are treated with AT-1 receptor antagonists compared to 2002.